EP Patent

EP4442252A1 — A tablet formulation of a solid dispersion comprising empagliflozin

Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2024-10-09 · 2y expired

What this patent protects

The present invention relates to a tablet composition comprising a tablet formulation comprising a solid dispersion of empagliflozin or a pharmaceutically acceptable salt thereof or crystalline polymorph thereof, wherein the solid dispersion further comprising at least one binder…

USPTO Abstract

The present invention relates to a tablet composition comprising a tablet formulation comprising a solid dispersion of empagliflozin or a pharmaceutically acceptable salt thereof or crystalline polymorph thereof, wherein the solid dispersion further comprising at least one binder, at least one surfactant and solvent. The present invention also relates to a simple, rapid, cost effective, timesaving and industrially convenient method of preparing the formulation.

Drugs covered by this patent

Patent Metadata

Patent number
EP4442252A1
Jurisdiction
EP
Classification
—
Expires
2024-10-09
Drug substance claim
No
Drug product claim
No
Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.